LTS announced that it has entered into a definitive agreement to acquire Gene.Sys, a leader in laboratory test cost calculation, process analysis and benchmarking. LTS Health is a leading provider of performance improvement products and services to the global diagnostics industry. The acquisition agreement takes place in LTS Health’s 20th year in operation. The transaction is subject to customary closing conditions and the receipt of required regulatory approvals.
Lab Management Seasonal School (LMSS) is a five-day course that provides delegates with the skills to perform optimally in a lab management role. The program for each LMSS features expert guest speakers, who provide insights into the lab's role in healthcare, as well as interactive facilitated training sessions on a variety of laboratory management topics. Various sponsorship opportunities exist for organisations interested in having a brand presence at LMSS.
LTS Health forms a strategic partnership with Clinical Lab 2.0
LTS has formed a strategic partnership with Project Santa Fe, the nonprofit formed by diagnostics expert and CEO at Lab 2.0 Strategic Services, Khosrow Shotorbani. Working closely with Project Santa Fe, LTS will support the development of the Clinical Lab 2.0 movement, which rallies the diagnostics industry to discuss, debate and add to the knowledge base which is informing the future business model of labs.